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Abstract
Background: Nearly all HIV infections in children worldwide are acquired through mother-to-child transmission
(MTCT) during pregnancy, labour, delivery or breastfeeding. The objective of our study was to estimate the number
and rate of new HIV diagnoses in children less than 13 years of age in mainland France from 2003–2006.
Methods: We performed a capture-recapture analysis based on three sources of information: the mandatory HIV
case reporting (DOVIH), the French Perinatal Cohort (ANRS-EPF) and a laboratory-based surveillance of HIV
(LaboVIH). The missing values of a variable of heterogeneous catchability were estimated through multiple
imputation. Log-linear modelling provided estimates of the number of new HIV infections in children, taking into
account dependencies between sources and variables of heterogeneous catchability.
Results: The three sources observed 216 new HIV diagnoses after record-linkage. The number of new HIV
diagnoses in children was estimated at 387 (95%CI [271–503]) from 2003–2006, among whom 60% were born
abroad. The estimated rate of new HIV diagnoses in children in mainland France was 9.1 per million in 2006 and
was 38 times higher in children born abroad than in those born in France. The estimated completeness of the
three sources combined was 55.8% (95% CI [42.9 – 79.7]) and varied according to the source; the completeness of
DOVIH (28.4%) and ANRS-EPF (26.1%) were lower than that of LaboVIH (33.3%).
Conclusion: Our study provided, for the first time, an estimated annual rate of new HIV diagnoses in children
under 13 years old in mainland France. A more systematic HIV screening of pregnant women that is repeated
during pregnancy among women likely to engage in risky behaviour is needed to optimise the prevention of
MTCT. HIV screening for children who migrate from countries with high HIV prevalence to France could be
recommended to facilitate early diagnosis and treatment.
Background
Nearly all HIV infections that occur worldwide in chil-
dren are acquired through mother-to-child transmission
(MTCT) during pregnancy, labour, delivery or breast-
feeding. Estimates have shown that there were nearly
430,000 new paediatric infections worldwide in 2008 [1].
Nearly all such infections can be prevented through
MTCT prevention programmes.
In France, the risk of HIV transmission from mother to
child has been dramatically reduced since the end of the
1980s through the prophylactic use of antiretroviral ther-
apy (ART) during pregnancy and the administration of
ART drugs to the baby during the first weeks of life. Cur-
rently, the risk of HIV transmission from mother to child
is approximately 1% [2]. The early diagnosis of HIV infec-
tion during pregnancy and early treatment of the mother
allow for the effective prevention of MTCT. In France, the
national policy since 1993 has been to offer universal vol-
untary HIV testing in the first trimester of pregnancy.
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Moreover, it was recommended in 2002 to repeat HIV
testing during pregnancy in women at high risk of HIV
transmission [3].
Of the 150,000 people living in France with HIV, it is
estimated that approximately 1,500 are children. In new-
borns, ten to fifteen new HIV infections are diagnosed
each year [4], an estimate based on the application of
the MTCT rate of 1% to the number of HIV-positive
pregnant women delivering each year in France. How-
ever, this estimate does not take into account infections
in children born abroad (in high endemic countries)
who are diagnosed after their arrival in France. Foreign-
born populations account for 5.3 million individuals,
which equates to approximately 8.3% of the total popula-
tion in France. Among these migrants, 5.8% are children
under 13 years of age, and 40% are living in the Paris
area [5]. Migrants are typically born in Europe (38.4%),
North Africa (30.1%), Asia (14.0%), or sub-Saharan
Africa (12.3%) [6]. Currently, there are no diagnostic
testing guidelines for children except for those born
from HIV seropositive mothers. Targeted screening is
recommended for migrants who originate from coun-
tries with a high prevalence of HIV; however, this
recommendation does not strictly include children [7].
In this paper, we estimated the total number and rate of
new HIV diagnoses in children less than 13 years of age in
mainland France between 2003–2006 using capture-
recapture methods. We used three data sources: the
mandatory HIV case reporting (DOVIH), the ANRS French
Perinatal Cohort (Enquête Périnatale Française) (EPF) and
the HIV laboratory surveillance system (LaboVIH). We also
assessed the completeness of the 3 sources along with the
combined completeness (case-ascertainment).
Methods
The capture-recapture method estimates the total num-
ber of cases of a disease after matching cases reported in
at least two sources [8].
Case definition
Cases were defined as all new HIV infections in children
under 13 years of age, according to microbiological criteria
[4], that were diagnosed in mainland France (the part of
France located in Europe) during the 2003–2006 period.
Description of the three data sources
The mandatory HIV case reporting (DOVIH)
The mandatory HIV case reporting system was imple-
mented in 2003 by the French Institute for Public Health
Surveillance (InVS) to follow the epidemic trends of
HIV and to describe the characteristics of HIV infections
in newly diagnosed individuals [9]. For adults, HIV
mandatory notifications are initiated by microbiologists
and then completed by clinicians. For children under 13
years of age, case reporting is performed only by paedia-
tricians. All HIV-positive cases are notified using an
assigned unique anonymous code that allows for the de-
tection of duplicates. To take into account reporting
delays, all notifications through March 31st, 2010 were
selected for the study.
The ANRS French Perinatal Cohort (ANRS-EPF CO1/CO10/
CO11)
Since 1984, the French Perinatal Cohort, supported by
the French National Agency for AIDS Research (ANRS),
has prospectively collected data on HIV-infected preg-
nant women and their children in approximately one
hundred centres throughout France [2]. The coverage of
the cohort was estimated at 70% of cases throughout
France. The objectives of this cohort study are to iden-
tify factors associated with HIV MTCT, to evaluate tol-
erance to ART prophylaxis, and to assess the prognosis
of paediatric HIV infection. Informed consent was
obtained from all of the mothers. Since 2005, the inclu-
sion criteria were extended to all children <13 years of
age diagnosed with HIV and born to mothers who were
not included in the EPF, with parental consent. For these
children, data were collected retrospectively for 2003
and 2004 and prospectively since 2005. Duplicates were
deleted. The cases were selected based on a database
that was updated in April 2008.
The HIV laboratory surveillance (LaboVIH)
Since 2001, the InVS has implemented a national sur-
veillance of the HIV testing activity in France. The num-
ber of HIV tests performed and the number of new
HIV-positive confirmed diagnoses are collected from
4,200 French microbiological laboratories each year [10].
The participation rate of this laboratory surveillance is
approximately 85%.
Laboratories that reported at least one new HIV diag-
nosis in children less than 13 years of age from 2003 to
2006 were asked to complete a questionnaire to collect
individual information for each paediatric diagnosis. Du-
plicate notifications were deleted.
Identification of common cases among sources
Because no common identification code was available
among the three sources, algorithms were established
using variables common to all three sources to identify
common cases. Year of birth, sex, reference hospital (or
district number) and date of diagnosis (or date of the
first medical care) were available in all three sources.
The algorithm that detected common cases between the
DOVIH and EPF sources also included the maternity of
birth for children born in France, or the country of birth
for children born abroad, the mother’s country of origin
and the vital status of the children. The identification of
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common cases among the sources was performed with
the SQL procedure in SAS© version 9.1 and was com-
pleted by a manual verification of matched records.
Imputation of the variable “country of birth” in the
source LaboVIH
We wanted to estimate the total number of new HIV
diagnoses according to the place of birth: “born in
France” or “born abroad”. This binary variable was not
collected in the LaboVIH source. However, this variable
was collected in the DOVIH and EPF sources. Therefore,
we were able to obtain the place of birth for the cases in
LaboVIH that matched the two other sources of infor-
mation (DOVIH and the EPF). The variable was missing
in two cases in DOVIH and was unavailable for 66/126
cases globally (30.6%). We estimated the missing values
through a multiple imputation (MI) method, in which
the distribution of the observed data is used to estimate
a set of plausible values for the missing observations
[11]. Multiple data sets were created, and an estimate
was calculated for each imputed data set. The estimates
were then combined to calculate overall estimates, var-
iances and confidence intervals.
The applied MI method was multiple imputation by
chained equations using STATA's user-written program
ice (STATA W 11.0, Stata Corporation, College Station,
Texas, USA) [12,13]. The variables “age” (continuous),
“region of diagnosis” (categorical) and “year of diagnosis”
(categorical) contained no missing values and were used
as predictors in the imputation model. One hundred
imputed databases were generated.
Capture-recapture estimates
The reliability of the estimates depended on the follow-
ing underlying assumptions: (1) identification of all and
only true common cases, (2) closed population, (3) inde-
pendence between sources and (4) capture homogeneity
[8]. Two sources are independent if the probability of a
case being reported in one source does not depend on
its probability of being reported in the other source. For
analyses involving three or more sources, the independ-
ence assumption is not crucial because interaction terms
can be incorporated into regression models to adjust for
source dependencies; however, in these cases, highest-
order independence has to be assumed. Homogeneity of
capture is fulfilled when the probability of a case being
reported in a source is the same for all cases or, more
simply, when the probability of registration does not de-
pend on the characteristics of the case (i.e., age, sex,
place of birth etc.). This probability may vary from one
source to another or be constant overall [8].
Dependence between sources was first assessed by
comparing the estimates provided by each pair of
sources [14,15] and calculating the odds ratio (95% CI)
between the two sources, as proposed by Wittes [8].
A preliminary three-source analysis was performed by
fitting eight log-linear models to the data arranged in a
23 contingency table, according to the presence or ab-
sence of each case in each source. The dependent vari-
able for each model was the logarithm of the number of
cases in each of the 7 non-empty cells of the contin-
gency table. These preliminary analyses assumed homo-
geneity of capture within each source and were
performed using STATA’s user-written program “recap”
[16], a STATA module providing standard three-source
capture-recapture analyses without covariates. The con-
fidence interval estimates for the population size were
computed according to a goodness-of-fit based method
proposed by Regal and Hook [17].
Three variables of potential heterogeneous catchability
were considered: place of birth (born in France; born
abroad), region of diagnosis (Paris area; other regions),
and year of diagnosis (2003 to 2006). The data were then
arranged in a 23x2x2x4 contingency table. Log-linear
models were fitted via the STATA ‘glm’ command, which
specified a logarithmic link and a Poisson distribution.
Stratified analyses were performed according to the
three variables of heterogeneous catchability. The log-
linear models included two-way interactions between
sources, between sources and each variable of catchabil-
ity, and between the variables of catchability, when ap-
plicable. Log-linear modelling was jointly performed for
the 100 imputed data sets using the STATA 11.0 analysis
module “mi estimate” applying Rubin’s rules.
Population size estimates, calculated as a sum of expo-
nentiated regression coefficients, were obtained through
commands specific to MI. Their respective variances
were estimated using the delta method. The confidence
intervals (CI) were computed using Student’s t-statistics
with degrees of freedom specific to each coefficient, de-
pending both on the number of imputations and on the
proportion of missing values.
Classically, in capture-recapture studies, the choice of
the final model is based on the likelihood ratio test stat-
istic (G2), the Akaike Information Criterion (AIC) and
the Bayesian Information Criterion adapted by Draper
(DIC), which are functions of the likelihood ratio statis-
tic [18,19]. AIC and DIC criteria were derived for each
imputed data set according to the following formulas:
AIC=G2− 2(df ) and DIC=G2− (ln(Nobs/2π))  (df ), where
df is the number of degrees of freedom associated with
any model.
The naïve approach that averages the likelihood ratio
statistic over the imputed data sets does not provide ac-
curate p-values [20]. The pooled likelihood ratio test
statistic and its corresponding p-value were calculated
using the Meng and Rubin approach [21], recently
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illustrated by Marshall et al. [22]. Each log-linear model
was constrained to the regression coefficients obtained
from the joint analysis (i.e., the average over the 100
imputed data sets, according to Rubin’s rules). The AIC
and DIC estimates were the average of the 100 AICs and
DICs. We selected the most parsimonious model among
the models with a goodness-of-fit p-value >0.05, and
with the lowest AIC and DIC values. We also considered
the relevance of including variables of heterogeneous
catchability in the model, both from an epidemiological
and a public health point of view.
The completeness for each source was estimated by
dividing the number of new HIV diagnoses reported in
each source by the total number estimated by the final
log-linear model. The completeness was also calculated
for each stratum of “place of birth”, “year of diagnosis”
and “region of diagnosis”.
The annual rate of new HIV diagnoses was the estimated
number of new HIV diagnoses divided by the size of the
population of children under 13 years old living in mainland
France up to December 2007 [23]. The rate was also calcu-
lated according to the place of birth, using the number of
children less than 13 years of age born in France or abroad.
Access to the 3 databases was authorised by the French
Commission Nationale de l' Informatique et des Libertés
(CNIL). No ethical approval was required for this research.
Results
Cross-matches
The three sources reported 216 new HIV diagnoses in
children under 13 years old in mainland France between
January 1st, 2003 and December 31st, 2006 (Figure 1).
Capture-recapture estimates
When performing two-source capture-recapture ana-
lysis, the estimate of the number of new HIV diagnoses
provided by matching the sources DOVIH and EPF (Nest
= 188; 95%CI [171 – 206]) was lower than the estimate
provided by matching LaboVIH and EPF (Nest = 261;
95%CI [224–297]) or LaboVIH and DOVIH (Nest = 330;
95%CI [272–389]), suggesting a positive dependence be-
tween the sources DOVIH and EPF. The Wittes odds
ratio confirmed the dependence between the sources
DOVIH and EPF (OR = 5.4; 95%CI [2.5-12.1]) and sug-
gested a positive dependence between LaboVIH and EPF
(OR = 2.2; 95%CI [1.0-4.8]).
Preliminary log-linear modelling using the three
sources and including the dependencies between sources
provided an estimate of 369 (95%CI [294–521]) new
HIV diagnoses during the 2003–2006 period (Table 1).
This model took into account two dependencies be-
tween sources (DOVIH*EPF and EPF*LaboVIH).
When considering the dependencies with variables of
catchability, the model with the lowest AIC and a likeli-
hood ratio test with p>0.05 provided an estimate of 387
(95%CI [271–503]) new HIV diagnoses during the same
period (Table 2). This model (model 7) included two
interactions between sources, and interactions between
sources and variables of catchability (DOVIH*place of
birth, EPF*place of birth, DOVIH*region of diagnosis,
EPF*region of diagnosis, LaboVIH* region of diagnosis,
and EPF*year of diagnosis). The estimated annual num-
ber of new HIV diagnoses decreased over time from 108
in 2003 to 89 in 2006 (Table 3).
The estimated completeness of the combined three
sources was 55.8% (CI 95% [42.9 – 79.7]), but varied
according to the source (Table 3). The completeness of
DOVIH (28.4%) and EPF (26.1%) were lower than that
of LaboVIH (33.3%). The completeness had slightly
decreased since 2004 in both DOVIH and EPF, particu-
larly during the last year (2006). The completeness was
greater in the Paris area than in other regions in the
three sources and was greater for children born in
France, compared with abroad, in the sources EPF and
LaboVIH.
Based on the estimated number of new diagnoses
obtained in Table 3, the rate of new HIV diagnoses in chil-
dren under 13 years old in mainland France was 9.1 per
million (CI 95% [5.7 – 12.5]) in 2006. This annual rate was
38 times higher in children born abroad (161.1 per mil-
lion) than in children born in France (4.2 per million).
Discussion
Our study provided, for the first time, an estimate of the
total number of new HIV diagnoses in children under
13 years old in mainland France during the 2003–2006
period (N = 387). The completeness of the mandatory
DOVIH: Mandatory HIV case reporting
EPF: ANRS-French Perinatal Cohort 











Figure 1 Distribution of new HIV diagnoses in the children
identified by the three sources (N=216).
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notification system (DOVIH) and the French Perinatal
Cohort (EPF) was under 30%. The observed number of
cases in the three linked sources was 56%.
Limitations and strengths
Possible violations of the underlying capture-recapture
assumptions could influence the validity of our out-
comes. Our estimates should be interpreted with caution
because the criteria of the capture-recapture method
have not been fully satisfied [8].
Identification of common cases
Record linkage was performed using a combination of
identifiers, including the year of birth. A limited number
of common cases were identified between registers and
were confirmed through subsequent manual validation,
thereby minimising the violation of the perfect record-
linkage assumption. Links may have been missed be-
tween the source LaboVIH and the 2 other sources,
potentially resulting in an under- or overestimation of
the number of new HIV diagnoses.
Closed population
The study period and the geographic area were the same
for all of the sources. However, it was estimated that the
EPF cohort covered 70% of the HIV-positive pregnant
women, which could have introduced a bias, which
would result in either an over- or underestimation of
our results.
Independence between sources
The positive dependence between the DOVIH and EPF
sources has been suspected prior to analysis. The heigh-
tened awareness of the paediatricians who participate in
the EPF cohort of the necessity of reporting to the
mandatory notification, as implemented in 2003, may
explain this dependence. Two large laboratories partici-
pated in both the EPF cohort and the laboratory survey,
Table 1 Preliminary log-linear analyses assuming homogeneity of capture within each source
Log-linear models n^ N^ 95% CI df G2 p AIC DIC
Dependencies between sources
LaboVIH*DOVIH, LaboVIH*EPF, DOVIH*EPF 126 342 259,573 0 0 1 0 0
LaboVIH*DOVIH, LaboVIH*EPF 23 239 225,263 1 18.83 <10-4 16.83 16.89
LaboVIH*DOVIH, DOVIH*EPF 58 274 243,331 1 3.78 0.05 1.78 1.84
LaboVIH*EPF, DOVIH*EPF 153 369 294,521 1 0.24 0.63 −1.76 −1.71
LaboVIH*DOVIH, EPF 29 249 234,272 2 18.49 <10-4 14.49 14.6
LaboVIH*EPF, DOVIH 51 267 245,300 2 30.12 <10-4 26.12 26.23
DOVIH*EPF, LaboVIH 85 301 268,349 2 5.96 0.05 1.96 2.07
LaboVIH, DOVIH, EPF 49 265 246,292 3 30.2 <10-4 24.20 24.36
DOVIH: Mandatory HIV case reporting; EPF: ANRS French Perinatal Cohort; LaboVIH: Laboratory surveillance of HIV testing activity.
n^ : Estimate of the number of diagnoses not reported to any source; N^ : Estimate of the number of diagnoses; 95% CI: 95% confidence interval for N^ ; df: number of
degrees of freedom; G2: deviance statistic; p: p-value of the deviance goodness-of-fit test; AIC: Akaike Information Criterion; DIC: Draper Information Criterion.
Table 2 Log-linear analyses incorporating variables of potential heterogeneous catchability
Log-linear models n^ N^ 95% CI
(N^ )
df G2 p AIC DIC
Model 1: DO*EPF, LABO*EPF, EPF*place 154 370 270 469 100 145,75 0,00 −54,25 −142,31
Model 2: DO*EPF, LABO*EPF, EPF*region 154 370 270 469 100 133,74 0,01 −66,26 −154,32
Model 3: DO*EPF, LABO*EPF, EPF*année, Labo*année 154 370 270 469 95 141,78 0,00 −48,22 −131,88
Model 4: DO*EPF, LABO*EPF, EPF*place, EPF*region, DO*region 147 363 266 460 97 125,12 0,03 −68,88 −154,30
Model 5: DO*EPF, LABO*EPF, EPF*place, EPF*year 131 347 260 434 94 132,81 0,00 −55,19 −137,96
Model 6: DO*EPF, LABO*EPF, EPF*region, DO*region, EPF*year 141 357 261 452 96 121,31 0,02 −64,69 −146,59
Model 7: DO*EPF, LABO*EPF, DO*place, EPF*place, DO*region, Labo*region, EPF*region,
EPF*year
171 387 271 503 93 112,72 0,07 −73,28 −155,17
Model 8: DO*EPF, LABO*EPF, DO*place, EPF*place, DO*region, Labo*region, EPF*region 171 387 271 503 96 112,48 0,05 −73,52 −158,06
DO: Mandatory HIV case reporting; EPF: ANRS French Perinatal Cohort; Labo: Laboratory surveillance of HIV testing activity.
n^ : Estimate of the number of diagnoses not reported to any source; N^ : Estimate of the number of diagnoses; 95% CI: 95% confidence interval for N^ ; df: number of
degrees of freedom; G2: deviance statistic; p: p-value of the deviance goodness-of-fit test; AIC: Akaike Information Criterion; DIC: Draper Information Criterion
Place: place of birth; region: region of diagnosis; year: year of diagnosis.
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which could result in a positive dependence between the
EPF and LaboVIH sources.
Capture homogeneity
Three variables of heterogeneous catchability were iden-
tified: country of birth, region of diagnosis and year of
diagnosis. The selected model included the 3 variables of
heterogeneous catchability and gave an estimate of 387
cases (Table 2), which was slightly higher than the model
including dependences between sources only.
Model selection and estimation
The final model selection in the stratified analysis that
included variables of catchability was based on the AIC
and DIC, assuming that the goodness of fit of this
model, according to the likelihood ratio test, is correct.
The approach proposed by Meng and Rubin was applied
to utilise the likelihood ratio test and provided p-values
slightly lower than the naïve approach (data not shown).
AIC/DIC criteria have been obtained by averaging their
values over the imputed data sets and therefore should
be interpreted with caution [20]. Differences between
models according to these criteria may be overestimated
and may have led to the selection of an overly complex
model.
Model 7 and model 8 give a similar estimate (387
cases). Despite a slightly higher AIC and DIC, we
retained model 7 due to its slightly better likelihood stat-
istic (p=0.07). Although model 7 is less parsimonious, it
includes a biologically plausible interaction term be-
tween EPF and year of diagnosis.
Estimating missing values
The variable ‘place of birth’ was not recorded in the
source LaboVIH but was nearly complete for the two
other sources. Typically, the standard approach in a
capture-recapture method is to ignore variables not
common to every source, which often leads to biased
estimates of the population size [24]. One commonly
used approach to the analysis of incomplete data sets is
to impute missing values and analyse the data set as if it
were complete. Such methods of single imputation are
not statistically valid, may yield biased estimates, and
lead to underestimated variances [25]. Two methods that
are currently recommended to handle missing values ad-
equately include the maximum likelihood estimation
(MLE) and MI. These methods are asymptotically
equivalent and require the same assumption that the
data are missing at random (MAR), i.e., the missing data
mechanism depends on observed values only [11,26]. In
our study, the variable “place of birth” was missing with-
out indication of an underlying mechanism in the Labo-
VIH source, which implied that the MAR assumption
had been met. Only few studies report the imputation of
unobserved values in capture-recapture applications.
Both MLE, using an Expectation Maximisation (EM) al-
gorithm [24,27,28], and MI were applied in these studies
[29]. Van der Heijden et al. [28] estimated missing
values for variables of heterogeneous catchability that
were not collected in all of the sources, such as gender
and region of residence. The authors stressed that the
Expectation Maximisation (EM) algorithm sometimes
involves complex numerical integration, especially dur-
ing step E (the algorithm computes the expectation of
the log-likelihood evaluated using the current estimate
Table 3 Estimates of completeness of each source (model 7)
Strata Total DOVIH EPF LaboVIH
N^ (95% CI) Nobs Compl
(%)
(95% CI) Nobs Compl
(%)
(95% CI) Nobs Compl
(%)




2003 107 (72.4;142.7) 60 55.8 (42.0:82.9) 30 27.9 (21.0;41.4) 28 26.0 (19.6:38.7) 30 27.9 (21.0;41.4)
2004 99 (68.9;129.4) 59 59.5 (45.6;85.7) 35 35.3 (27.0;50.8) 32 32.3 (24.7;46.5) 35 35.3 (27.0;50.8)
2005 91 (62.4;120.9) 53 57.8 (43.8;85.0) 27 29.5 (22.3;43.3) 27 29.5 (22.3;43.3) 34 37.1 (28.1;54.5)
2006 88 (55.4;121.8) 44 49.7 (36.1;79.4) 18 20.3 (14.8;32.5) 14 15.8 (11.5;25.3) 30 33.9 (24.6;54.2)
Place of birth
France 152 (100.3;204.9) 86 56.4 (42.0;85.7) 37 24.2 (18.1;36.9) 47 30.8 (22.9;46.8) 55 36.0 (26.8;54.8)
Foreign
country
234 (158.9;309.9) 130 55.5 (42.0;81.8) 73 31.1 (23.6;45.9) 54 23.0 (17.4;34.0) 74 31.6 (23.9;46.6)
Region of diagnosis
Paris area 198 (154.7;241.4) 139 70.2 (57.6;89.9) 79 39.9 (32.7;51.1) 79 39.9 (32.7;51.1) 82 41.4 (34.0;53.0)
Other regions 188 (101.0;276.8) 77 40.8 (27.8;76.2) 31 16.4 (11.2;30.7) 22 11.6 (7.9;21.8) 47 24.9 (17.0;46.5)
Total 387 (271;503) 216 55.8 (42.9;79.7) 110 28.4 (21.9;40.1) 101 26.1 (20.1;37.3) 129 33.3 (25.6;47.6)
DOVIH: Mandatory HIV case reporting; EPF: ANRS French Perinatal Cohort; LaboVIH: Laboratory surveillance of HIV testing activity.
N^ : Estimate of the number of diagnoses; Nobs: Number of diagnoses observed; Compl: Completeness; 95% CI: 95% confidence interval for completeness.
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for the parameters), and that MI has the advantage of
being computationally much simpler for situations with
incomplete continuous variables. Zwane et al. [29]
demonstrated in their study that MI performed well in a
capture-recapture application. They estimated missing
values for both continuous and categorical variables of
heterogeneous catchability and concluded that MI is
preferred to MLE in these circumstances. In our study,
the incomplete variable was categorical. Although MLE
could have been applied, the MI approach was preferred
because it could be implemented in most general statis-
tical software.
When building the imputation model, it is recom-
mended to include any variables that may be used in the
subsequent analyses [30]. The following variables were
complete within our databases and used as predictors:
age, sources, year of diagnosis, and region of diagnosis.
Because the variable ‘country of birth’ was missing in
LaboVIH, the twofold source*covariate interaction terms
were not included in the imputation model. Therefore,
the imputation process was assumed to be conducted
under the assumption of zero correlation between the
omitted variables and the outcome. As a result, the esti-
mates associated with these interaction terms could be
biased toward zero [30,31].
According to Graham et al. [30,32] and White et al.
[20], it is recommended to generate a number of data-
bases at least equal to the percentage of incomplete
cases, or at least 30 databases in our study. Because only
one variable was incomplete, we chose to impute a lar-
ger number of databases.
One advantage of MI is that the standard errors and
CIs of the estimates are directly available as part of the
model estimation. A parametric bootstrap approach has
been recommended to calculate CIs for the final esti-
mates [33,34]. This method yields asymmetrical CIs and
allows one to take model uncertainty into account. Fu-
ture research should address the possibility of combining
this parametric bootstrap approach with MI.
Estimates of the number of new HIV diagnoses
Among the 89 estimated new HIV diagnoses in children
under 13 years old in 2006, 40 occurred in children born
in France. This estimate is more than twice the expected
annual number of cases cited by Yeni [4]. However,
Yeni’s estimate did not take into account women who
are not tested for HIV during pregnancy or women who
seroconvert during pregnancy following a first negative
test. Both scenarios create a much higher risk of trans-
mission from the mother to the unborn baby. Prior to
1994 in France, in the absence of any prevention strat-
egy, the HIV MTCT rate was approximately 20% [35].
Such high-risk situations were identified in a
retrospective analysis of children diagnosed with HIV in-
fection at Necker Hospital in Paris [36].
Our capture-recapture findings allowed us to estimate
a rate of new HIV diagnoses in children in mainland
France in 2006 of 9.1 per million. This rate was 38 times
greater for children born abroad than for those born in
France. This ratio is higher than that observed in adults;
the rate of new HIV diagnoses in adults born abroad is
6.0 per million, compared with 0.6 per million in those
born in France [10]. The higher ratio observed in chil-
dren can be explained by lower access to HIV screening
and prevention of MTCT during pregnancy in HIV-
endemic countries.
Our results can be compared with data from the Uni-
ted Kingdom because both countries have similarly sized
populations (the U.K. has a population of approximately
60 million, including 10 million children), similarly con-
centrated HIV epidemics and similarly sized foreign-
born populations (the U.K.’s foreign-born population is
approximately 8% of the total population, with approxi-
mately 0.5 million from sub-Saharan Africa). In 2006,
the rate of new HIV diagnoses in children under 15 in
the U.K. was slightly higher (10.1 per million) than our
estimate for France. This discrepancy is likely due to dif-
ferent HIV prevalence rates within the countries of ori-
gin of each country’s foreign-born population. In the
U.K., the foreign-born population is primarily from
Eastern or Southern Africa. The foreign-born popu-
lation in France is primarily from Western or Cen-
tral African countries, where the HIV prevalence is
lower. As in France, the number of new diagnoses in
children in the U.K decreased from 2003 to 2006
(from 148 to 117) and has continued to decline
since then [37]. Additionally, as in France, approxi-
mately two thirds of children diagnosed as HIV-
infected in the U.K. were born abroad [38].
Completeness
The completeness of the mandatory notification of new
HIV diagnoses in children was low (28%) compared with
that of the overall DOVIH system for HIV in children
and adults (62% in 2004) [10]. This discrepancy could be
explained by the compulsory pre-notification from la-
boratories by microbiologists for adult HIV, which facili-
tates DOVIH reporting by clinicians. The notification
system of HIV infection in children was modified in
2007 to require microbiologists to report new HIV diag-
noses in children. However, low completeness and modi-
fication of the surveillance system make it difficult to
assess potential trends in new HIV diagnoses that have
occurred since 2007.
Several hypotheses may explain the low completeness
for HIV diagnoses in children in EPF (26%). Approxi-
mately 70% of HIV-infected pregnant mothers and their
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children have been included in the EPF cohort. Cases of
HIV-infected children born to mothers who were not
included in EPF, and especially to those who delivered
abroad, may have been missed for two reasons: (i) data
have been collected retrospectively for 2003 and 2004,
and (ii) parental consent after HIV diagnosis in children
is sometimes difficult to obtain for paediatricians.
Conclusion
Our study provided, for the first time, an estimated an-
nual rate of new HIV diagnoses in children under 13
years old in mainland France. A more systematic HIV
screening of pregnant women that is repeated during
pregnancy among women likely to engage in risky be-
haviour is needed to optimise the prevention of MTCT.
The high prevalence of HIV infection in certain regions
of the world, especially in sub-Saharan Africa, could jus-
tify screening guidelines for children who migrate to
France, as is currently recommended for adults. Thus,
children diagnosed as HIV-infected would benefit from
an early and appropriate treatment. Notification of new
HIV diagnoses in children should also be improved to
better describe the evolving epidemiology of HIV infec-
tion in children.
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